• Bacitracin (B1670): Practical Guide for Antibacterial Resear

  2026-06-16

  Bacitracin (B1670) is a peptide antibiotic formulated for laboratory workflows targeting bacterial cell wall and peptidoglycan synthesis disruption. It is suitable for antibacterial research involving both gram-positive and gram-negative bacteria, but is strictly not for diagnostic or medical use.

• Filipin III: Gold-Standard Cholesterol Detection Reagent

  2026-06-16

  Filipin III, a polyene macrolide antibiotic, is the benchmark for membrane cholesterol detection and visualization via fluorescence microscopy. Its high specificity for cholesterol and robust performance in cell membrane studies make it indispensable for research in immunometabolism and membrane biochemistry.

• Biotin Azide: Precision Biotinylation for Click Chemistry As

  2026-06-15

  Biotin Azide enables rapid, high-purity biotin labeling of alkynylated biomolecules via click chemistry, streamlining affinity purification and detection workflows. Its compatibility with bio-orthogonal labeling and robust performance in lipid-protein interaction studies make it an essential tool for dissecting complex signaling pathways such as Wnt/β-catenin-cholesterol crosstalk.

• Pharmacogenomics of Chloroquine and Hydroxychloroquine: Evid

  2026-06-15

  This review systematically assesses the pharmacogenomic determinants of chloroquine and hydroxychloroquine safety and efficacy, emphasizing the impact of cytochrome P450 genetic variants on clinical outcomes. The findings highlight the importance of incorporating CYP2C8, CYP3A4/5, and CYP2D6 genotyping in precision medicine strategies for these widely used agents.

• Angiotensin Peptides Potentiate SARS-CoV-2 Spike–AXL Binding

  2026-06-14

  The referenced study demonstrates that naturally occurring angiotensin peptides, including Angiotensin III, significantly enhance the binding of the SARS-CoV-2 spike protein to the host AXL receptor. These findings reveal a new mechanistic link between the renin–angiotensin system and COVID-19 pathogenesis, with implications for cardiovascular and infectious disease research.

• Dihydroethidium: Applied Superoxide Detection in Redox Assay

  2026-06-13

  Dihydroethidium (DHE) empowers precise, live-cell quantification of superoxide anions, enabling breakthroughs in oxidative stress and apoptosis research. This guide details best-practice workflows, critical troubleshooting, and novel translational use-cases, anchored by recent advances in nanoparticle-mediated ROS biology.

• Reliable Assays with WY-14643 (Pirinixic Acid): Lab Scenario

  2026-06-12

  This article addresses key laboratory challenges in cell viability and metabolic research, providing scenario-driven, evidence-backed guidance for using WY-14643 (Pirinixic Acid), SKU A4305. It highlights workflow optimization and data reproducibility, connecting real-world bench needs to validated protocols and robust supplier reliability.

• Verapamil HCl: Applied Workflows for Calcium Channel Blockad

  2026-06-12

  Verapamil HCl, a trusted L-type calcium channel blocker, is reshaping experimental design across apoptosis, inflammation, and bone metabolism research. This guide translates recent breakthroughs and hands-on protocol insights into actionable workflows for advanced cell and animal models—bridging mechanistic discovery with reproducible lab results.

• Remdesivir (GS-5734): Atomic Facts and Protocols for Antivir

  2026-06-11

  Remdesivir (GS-5734) is a validated antiviral nucleoside analogue that potently inhibits RNA-dependent RNA polymerase in RNA viruses. The compound demonstrates submicromolar EC50 values in both coronaviruses and filoviruses, with robust efficacy in cell-based and in vivo models. This dossier distills atomic, verifiable facts and practical parameters for reproducible antiviral research.

• Hexamethonium Bromide in Sex-Dependent Hypertension Research

  2026-06-11

  This thought-leadership article explores how Hexamethonium Bromide, a selective antagonist of neuronal-type nicotinic acetylcholine receptors, is transforming translational research into sex differences in autonomic regulation and hypertension. Integrating mechanistic insights, experimental validation, and strategic protocol guidance, the article charts a path for researchers to leverage this tool for next-generation discoveries.

• Uremic Metabolite Adsorption to Hydroxy-PEO Films: Implicati

  2026-06-10

  This study investigates how uremic metabolites, including 4-ethylphenyl sulfate, adsorb to hydroxy-terminated PEO (PEO–OH) films of varying chain densities. The findings reveal that metabolite structure and film properties critically influence adsorption, highlighting the need to account for disease-associated metabolic changes when designing blood-contacting biomaterials.

• 11β-HSD1 Inhibition Attenuates Liver Fibrosis via Notch Path

  2026-06-10

  A recent study demonstrates that selective inhibition of 11β-HSD1 markedly reduces liver fibrosis by suppressing the Notch signaling pathway and enhancing natural killer (NK) cell-mediated clearance of hepatic stellate cells. These findings provide mechanistic insight into immunometabolic regulation in metabolic dysfunction-associated steatotic liver disease (MASLD) and offer a new therapeutic avenue for chronic liver injury.

• MG-132 in Proteasome Inhibition: Advanced Insights for Apopt

  2026-06-09

  Explore the molecular intricacies of MG-132, a potent proteasome inhibitor, in apoptosis and cancer research. This article provides an advanced analysis of MG-132's mechanism, protocol optimization, and integration of cutting-edge findings on caspase-8-mediated cell death.

• Applied Use-Cases of PF-04971729 (Ertugliflozin) in Diabetes

  2026-06-09

  PF-04971729 (Ertugliflozin) empowers translational scientists with unmatched selectivity in SGLT2-mediated glucose transport workflows, offering robust glycemic, weight, and renal endpoints. This guide delivers actionable protocol enhancements, troubleshooting strategies, and cross-domain insights for high-impact diabetes and inflammation studies.

• Pentoxifylline: Mechanistic Leverage for Translational Immun

  2026-06-08

  This article delivers a strategic, mechanistic, and evidence-driven exploration of Pentoxifylline as a non-specific phosphodiesterase inhibitor. It bridges foundational biochemical insights with applied best practices for translational researchers, highlighting protocol design, clinical translation, and competitive advantages. Anchored in recent experimental data—including age-dependent immunomodulation in neonatal sepsis—this thought leadership piece guides scientists toward more reproducible and impactful inflammation research.

444 records 14/30 page Previous Next First page 上5页 1112131415 下5页 Last page